AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Mankind's Bold Move into Infertility Market
This chapter examines Mankind Pharma’s acquisition of Bharat Seram and its implications for growth in the infertility segment of the Indian market. It discusses the strategic shift towards specialized products, market dynamics, and the rising interest from multinational corporations in India's pharmaceutical landscape. The chapter highlights the transformative potential of these acquisitions in solidifying Mankind's position and expanding its market reach amidst a rapidly evolving industry.